Delivery Order SPE2DB22D1002-SPE2DB25FLHJ0
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,168.96 delivery order for AREXVY vial kits under contract 4568853131 on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement to support federal medical supply requirements. The contract will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,440.44 to AmerisourceBergen Drug Corp for AREXVY vial kits on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $10,936.01 to AmerisourceBergen Drug Corp for AREXVY vial kits on August 19, 2025, with completion expected by August 20, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $45,471.50 to AmerisourceBergen Drug Corp for AREXVY vial kits, with an ultimate completion date of August 21, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is being performed at the contractor's location in Conshohocken, Pennsylvania. The award was issued on August 20, 2025, as part of the federal government's ongoing pharmaceutical supply chain management. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, located in Conshohocken, Pennsylvania. The $1,707.90 contract is for the provision of AREXVY VIAL KITS and has a completion date of December 6, 2023. This order is not set aside for any particular business type. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a leading global pharmaceutical sourcing and distribution...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for Arexvy vial kits with a ceiling value of $1,440.44. The contract is a firm fixed price delivery order with a completion date of September 5, 2025, and was awarded on a competitive basis without a set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,440.44 to AmerisourceBergen Drug Corp for AREXVY vial kits on September 3, 2025, with an ultimate completion date of September 4, 2025. AREXVY is a prescription medication used in the treatment of systemic sclerosis. This firm fixed price delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AREXVY VIAL KITS. The contract has a potential value of $1,707.90 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $43,623.36 to AmerisourceBergen Drug Corp on August 9, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, was competitively awarded with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $2,807.37 to AmerisourceBergen Drug Corp on September 2, 2025, with completion targeted for September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The delivery order will be fulfilled...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHJ0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for AREXVY vial kits under a firm fixed-price contract valued at $2,160.66. This non-set-aside award was made on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a child delivery order issued against a larger contract vehicle. The contractor's place of performance is located in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a broad range of brand-name and generic medications, vaccines, and specialized medical supplies. The company's federal contract portfolio demonstrates consistent competitively awarded delivery orders with firm fixed pricing across multiple therapeutic domains to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/8/25 |